| P2093 | author name string | Adam S Faye | |
| | Kimberly Cheng | |
| P2860 | cites work | Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al. | Q55055349 |
| | Use of Glucocorticoids and Risk of Venous Thromboembolism | Q56644956 |
| | The influence of glutathione and other thiols on human platelet aggregation | Q70318030 |
| | Platelets circulate in an activated state in inflammatory bowel disease | Q72330632 |
| | Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease | Q74260277 |
| | Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis | Q81164126 |
| | Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease | Q84142091 |
| | Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease | Q85645656 |
| | Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients | Q86502794 |
| | Thromboembolism as an important complication of inflammatory bowel disease | Q86580963 |
| | Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center | Q86851911 |
| | Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease | Q87412769 |
| | Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study | Q88568709 |
| | The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: A systematic review and meta-analysis | Q90372541 |
| | Cost-Benefit Limitations of Extended, Outpatient Venous Thromboembolism Prophylaxis Following Surgery for Crohn's Disease | Q90610155 |
| | Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme | Q90623544 |
| | Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis | Q90655258 |
| | The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study | Q90842153 |
| | Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease | Q91123223 |
| | Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort | Q91328758 |
| | Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors | Q91501814 |
| | A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease | Q91845176 |
| | Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases | Q92123911 |
| | Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol | Q93070227 |
| | Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review | Q93141571 |
| | Review of the cost of venous thromboembolism | Q26781947 |
| | Management of venous thromboembolism: an update | Q28071443 |
| | Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial | Q28354097 |
| | Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease | Q30278690 |
| | Risk of venous thromboembolism during the postpartum period: a systematic review | Q33827298 |
| | Inflammatory bowel disease: the role of environmental factors | Q33980373 |
| | Risk assessment for recurrent venous thrombosis | Q34153343 |
| | Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases | Q34173855 |
| | Inflammatory bowel disease and thromboembolism | Q34326640 |
| | Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. | Q35012116 |
| | Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation | Q35069554 |
| | Review article: inherited thrombophilia in inflammatory bowel disease | Q35158989 |
| | Thrombosis in inflammatory bowel diseases: what's the link? | Q35368162 |
| | Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? | Q35596373 |
| | Venous thromboembolism: disease burden, outcomes and risk factors | Q36230821 |
| | Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis. | Q36909593 |
| | Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. | Q37660669 |
| | Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs | Q38024827 |
| | Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment | Q38058380 |
| | Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology | Q38181777 |
| | Pregnancy-Related Mortality in the United States, 2011-2013. | Q38684110 |
| | Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities | Q38735146 |
| | Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period | Q38992102 |
| | Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015. | Q39244248 |
| | Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort | Q39745686 |
| | Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity? | Q40876895 |
| | A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States | Q43462470 |
| | A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer | Q43857614 |
| | Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study | Q44355973 |
| | Venous thromboembolism in inflammatory bowel disease | Q44700471 |
| | Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study | Q45061360 |
| | Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients | Q45226332 |
| | Venous thromboembolism in adult hospitalizations - United States, 2007-2009. | Q47657187 |
| | Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Q47758448 |
| | Deep vein thrombosis: pathogenesis, diagnosis, and medical management | Q49332595 |
| | Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease. A meta-analysis | Q50003119 |
| | The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery | Q50006672 |
| | Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. | Q50553326 |
| | Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease. | Q53088997 |
| P433 | issue | 12 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| | venous thromboembolism | Q9397786 |
| P304 | page(s) | 1231-1241 | |
| P577 | publication date | 2020-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Venous thromboembolism in inflammatory bowel disease | |
| P478 | volume | 26 | |